Daxxify

daxibotulinumtoixnA-lanm

Approval

ApplicationBLA 761127
Approval dateSep 7, 2022
Approval year2022
SponsorRevance Therapeutics, INC.

FDA-approved use

To treat moderate-to-severe glabellar lines associated with corrugator and/or procerus muscle activity

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Daxxify: